Yu Jing
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 56
- Acute Myeloid Leukemia Research 44
- Hematopoietic Stem Cell Transplantation 14
- Chronic Myeloid Leukemia Treatments 13
- Genetics 13
- Chronic Lymphocytic Leukemia Research 7
Yu Jing
63 papers receiving 665 citations
Peers
Comparison fields: 5 of 68
- Hematology 443
- Genetics 127
- Cancer Research 135
- Molecular Biology 301
- Immunology 78
Countries citing papers authored by Yu Jing
This map shows the geographic impact of Yu Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Jing more than expected).
Fields of papers citing papers by Yu Jing
This network shows the impact of papers produced by Yu Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Jing. The network helps show where Yu Jing may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Jing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 8 | |
| 9 | 2020 | 37 | |
| 10 | 2017 | 75 | |
| 11 | 2017 | 1 | |
| 12 | 2017 | 23 | |
| 13 | 2016 | 30 | |
| 14 | 2016 | 8 | |
| 15 | 2016 | 13 | |
| 16 | 2015 | 10 | |
| 17 | 2014 | 3 | |
| 18 | 2012 | 66 | |
| 19 | 2012 | 25 | |
| 20 | Diagnostic significance of combined detection of serum anti cyclic citrullinated-peptide antibody and rheumatoid factor in rheumatoid arthritis | 2009 | 1 |
About Yu Jing
Yu Jing is a scholar working on Hematology, Genetics, Emergency Medicine, Cancer Research and Oncology, having authored 74 papers that have together received 667 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (44 papers), Hematopoietic Stem Cell Transplantation (14 papers), Chronic Myeloid Leukemia Treatments (13 papers), Acute Lymphoblastic Leukemia research (13 papers), Hematological disorders and diagnostics (8 papers), Histone Deacetylase Inhibitors Research (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Neutropenia and Cancer Infections (7 papers). The work is most often cited by research in Hematology (443 citations), Genetics (127 citations), Cancer Research (135 citations), Molecular Biology (301 citations) and Immunology (78 citations). Yu Jing has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Li Yu, Liping Dou, Yonghui Li, Lili Wang, Na Lv, Qingyu Xu, Sai Huang, Wenrong Huang, Yan Li and Jian Bo. Their work appears in journals such as Oncotarget, Transfusion, Annals of Hematology, Bone Marrow Transplantation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.